Upload
lyu-jh
View
47
Download
5
Embed Size (px)
Citation preview
1
8 1
()
1. 100 7 1 101 2 19 1,118 1,644 B
2. 100 266 7,665 100 10 1 65 6 100 2 13 257.4 97.5%
2
3. 25% 100 12 1 101 3 31
4. 1 101 1 3
2 16 24
288 86
3
4 101 2 17 2,856
5
6 9 1 2 ICU
3
3 /4
() 1. 71
100 58 3 101 2 19 11
2. 100 71
3. 71
4. 100
5.
4
5 100
()
1. 1001012191,5431,165 149 99 95 24 4411 1 10 13 (101)(100)
2.
3. 100 9
1 100 9 13 100 11 21 10 20
5
100 6 1 10 21 28 10 11
210 100 20
4. 101 1
2
3
6
4
5
6
()
1.
2. (DOTS)100 14,607 90%
3. (MDR) 96 5 100 100 212
4. 100 4,842 99 98
()
1. 3
7
0800-010-569
2. 100 12 21 () 928 374 1 100 1 12 28 8,751 349 90%
3. 100 1 12 7 5,040
4. 96 100 45 100 12 10,240
()
1. 100 100
8
490 100 10 100%
2. 99 2011 Asia Pacific Hand Hygiene Excellence Award 323 100 7 311
3.
4. carbapenem
5. 100 100 33 44
9
()
1. (OPV) 100 9 Tdap-IPV
2. 5 99 (PCV)101 PCV 5 4.3
3. 100 10 75
4. /
()
1. 100 9 16
10
1
2
3 63
50 4
2. 98
100 12 191 19 79 24 55 112 191
3.
1 9 17 24
11
2 13 8
() 1.
99 7 1 100 82 204 520
2. 100 39 601
3. 14 100 12 136 2 1,000
4.
12
100 12 48 103 1 1
5. 100 19
6. 100 100 5 45 7 40
() 1. 9
19,143 4
2. 110 105 96 1 4,131 100 3 6,628 94 71.5% 100 5%
13
3. /100 6.51 16.54
()
1. 100 22 300 100 12 123,748 480,195 3.88 43.37%
2. 97 7 4 99 1,696 95%100 12 1,211 1,164 96.12%99 27 100%100 12 40 39 97.5%
3. 99 3,889 10
14
16.8 98 4,063 10 17.6 174 4.3% 86 10 11 100 1-11 3,102 99 494 14%
() 1.
505 238 7 14
2. 100 136 4 73 5
3. /58
4. 1 10
15
(2) 3 1
2
3
() 1. 6
11 2. 100 1 1
200
3. 100
4.
5. 1100
16
83 37
2100 11 1
3 100 100 8
4100 15
6. 1 100 225 5 295 100
2,918 ( 1,450 1,468 ) 3100 69
2,488 101 80 4 100
101
7.
17
1003248()1553.4
8. 10092839
() 1.
2.
3.
18
4.
5. 6
() 1. 1
100 12 276
2 100 12 208
3 100 12 150
2. 100 12 IC 32
3. 100 12 198 175
19
() 1.
2. 100 85 3 0,524 3,655 7,248 1 8,813 948 5 6,700 4,480
3.
1100 619 3
2() 115 135 6 62 1
3 64 79 1 8
4. 24
20
100 301 275 91.4%
5. 100 776100 32 27
6. HIS 100 48 32 (PACS)100 3,364
() 1. 1
2(22 )(63 )(368
) 3()
4
21
2. 1
99 100 12 99 99 100 12 4,330 99 100 1 5,117
2() 99 5100 8
3. 1 1
97 2.3%98 5.7%99 16.3% 100 21%
2 100 61,675 97 3.5
22
3 6,346 45 CDR
2 100 99 100 30
4. 7 7 8
5. 98 7 23
1 99 35 2.98%100 ( 1 )
23
100 11
2 100 4 101 7,000
3 100 7 1,900 1017
4()()
5
6 98 9 100 11
24
81 225
()
1. 99 4 1 100 12 62
2. 100 1 26
3. () 100 12 17.69
25
4. 100 12 680 2.72%
5. 7 100 12 1
()
1. 1(Tw-DRGs)
299 1 155 100 1 164 17% 1,029 60% 5 100 1 18
26
DRG
3(Tw-DRGs)
4 100 1 11 4.39 4.17 5.01% 4 5,474 4 5,314 160 0.35%
2. 1100
2 100 2 23 3
27
25 7 15 100 7 1 103 6 30 101 1 1 103 12 31 3
3
3. 100 14.78 100 1 1 17% 2 3 4 101 21.4 100 9 16 17 101 9.099 12.389 100 8 RBRVS 37 100 9 11
28
101 3
4. (1)(2)(3) 3 100 377.2
()
1. 100 12 307 226
2. 1100 12
3,872 2.41 18.7 43.79 2,646 1,806
2100 100 12 1.48 3.5
29
3. 100 12 5,128 1 4,078
4.
100 12
118 17.8
2 16.9 3
5.1
5. (IDS) 48
()
1. 90
30
99 12 20 5
2. 99 150() 100 ()
3.
4. 98 12 100 190 55 0.099 5%
() 1. 100 1
4 100 1 26 1 2
2.
31
1
2
3 30 16
4
5
6
32
101 2 19 1668 ( 108 )
()
1. 100 481 46 2,110 200 100 12 145
2. 100 55 481
() 1. 1100 259
2100
3,141 2,955 94.1%
3 100 1 1
33
100 42 0,774
4 100 3 20() 100 12 31 17,188 3 12 3 26 ()
5 101 18
2.
1100 5 28
34
5 100 5 31 614 8 1
2 100 5 31 7 20 4 9,652 4,076 2 9,337 6 11 100 7 28 5723.2617 18.7948 5704.4669 100 7 29
3 5 28 7 25 131 4,150 100 1,099
35
4 100 7 20 49 3,180 20
5 31 34 100 6 22
6 100 7 13 (TDI) 100 10
36
7
393 4,266
3. 1
99 9 9 0991301731 100 1 1 101 4 30 100 12 606 99 11 29 0991302917 101 4 30
2 100 9 28
()
37
1. cGMP 100 12 162 10 3 22 145 GMP 34 PIC/S GMP
2. 100 1,041 203 20 201 1 2 600 8 5 1
3. 99 1 100 12 1 6,562 4 7,358.3 99 1 13.9% 100 12 4.95%
4. (1)
(2)
38
(3) 100 140 30 27
(4) 100 826 163 663 51
(5) 100 284
5. GMP 116 100 GMP 60
6. 100 262 13
7. 100 385 2,346.9
8. 100 7 20
9. 100 8 29 100 12 1 100 67
10. 18
11.100 10 15 16 100
39
31 51 7
12.Journal of Traditional and Complementary MedicineJTCM 100 10 10
13.100 2
() 1. (1)
100 121 99 67
(2)
(3) (DMF)100 6 21 (DMF)
(4) 100
40
12 (General Clinical Research Center,GCRC)
(5) 100 11 1 101 1
2. (1)
(2)
() 1.
100 15,247 143 0.94%
2. 100 16,351 99 1 8,792 13.0%
3. 100 6 2 4 6 14
41
4. 1 2 98 11 10
()
1. 100 12 431 100 3 3 96 100 12 6 1
() 1. 10 1 99
153 1 98.3%100 1 10 153 94.05% 99 100 100 10 1,015 101
42
2. 100 1 11 1
1,656 300 19 1,613 3,206 4,059 1,639 100 1 12 19 7,789 3,206
3. 100 1 12 1 461 608 5,821
4. 100 12 158 71.4%99 67.2% 1 99 58.5% 100 61.8%99 11 24 100 5 11 100 12 1,548 99.8%
5.
43
28 4 1 10 50 99 1.090 100 1.079 16 1.134 18
6. 99 12 8 100 4 7
44
100 1 1 100 12 29 3 4
()
1. 4 5100 1 12 35 2,375 97.4% 98%
2. 99 100 1 10 42 101 100 1 12 3 4 17 9,898 91.38% 97%
3. 5 1 99 27 7,639 100 1 10 25 4,971 100 22 2,661152
4. 7 7 99 1031 1 98.3%100 1 10 84 80.5% 100
45
5. 22 1 6 14 2 4 42
6. 99 100 26 22 4 8 99 100 2 4,400 99 100 2 3
7. 99 3 12 5,054 100 1 10 2,039
46
8. e 100 1 12 39 735 3,045 31 Teens 9 1,981 19 87 113 2 6,264 62 51 414 msn 217
()
1. 40 64 3 1 55 65 1 99 178 100 1 11 170
2. 3 103 6 166 14 416 582
3. 18 62.3%
47
44.6% 4. 20
22 7 5 3,843 2 3,958 3 6,418 90%
5. 687 1,986 2 5
6. 45 16 18 9 2
7.
8. 100 536 1,400
9. 483
48
100 174 101 101 186 22 100 6,532 4,239
10. 2011 Diabetes Education and Prevention 4,000
11. 100 126 2 1,401 6 3,357 50 33 22 2,881 12 5,305 65
12. 100 9 65 81 100 1 12 50 69 42.6 50-69 76.4 65
49
537 100 1 10 3,959
13. 100 1222 1,333 477 26%99 100 60%
14. 99 100 100 12 13 101 1 19 7 20 105 186 11 15 10 3 3
15.
50
WHO-99 100 9 20 101 20
16. 100 12 22 929 3 424
()
1. 18 99 64.1% 100 65.1%
2. 91 22
51
1 8,970
3. 8 45 100 12 30 101
4. 100 16 104 107 4
5. 100 13
6. AFHC 100 12 7 11 AFHC2
52
30 2 34 9 3,000
7. 100 1 12 2 417
8. 94 100 29 100 12 19
9. 96 100 100 12 46
10. 100 3 1
11. 1 100 12 76 WHO
53
100 6 19 101 20
2 100 12 4 Health Care Without HarmHCWHThe First Global Climate and Health Summit WHO TF on HPH and Environment 12 6 HCWH UNFCCC 17 WHO Dr.Maria NeiraHCWH Josha Karliner 50
3 100 12 8 UNFCCC 17 Climate Change and Public Health: Healthy Climate, Healthy People, Healthy Economy WHO TF on HPH and Environment WHO The First Global Climate and Health Summit
54
12. 96
100 12 7,411 303
13. 3,696
14. 100 100 1 460 92 604 ( 39.84%) 126
() 1. 22 100
60 600 22
55
2.
3.
4.
5. 100 12 31 1 1,880 72 1,104
() 1. 100
99 19.8% 19.1%99 9.1% 8.2%
2. 100 1 12 38 1,864 1 130 8,770 796 647
3. 100
56
4. 100 101 53 32
5. 100 85 448 44
6. 100 183 3 5412
7. 100 1 12 8,567 50
57
8. 100 1 12 9 8,486 1,957 100110108,922
9. 49 100 12 953 9 8,267 9,706 3 6,746 3 87.64%( 5,912)
10. 98 6 4 100 12 112 2,223
()
1. 97 174.4 99 171.3 1.8% 97 10 94.4 99 93.9 0.5% 104 98 10%
2. 92 96 41.1% 93 97 42.3% 1.2%
58
58.1% 59.2% 1.1% 3. 100
1 12 431 214 55.7 76.4 84.9 101 1 12 4,320 9,360 2,584 1,641 1 6,078 1,319 1,591
4. 100 36 6 HPV100 1 12 6.1
5. 100 HPV 3,654 3 HPV 48% 1,980 3 HPV 14%
6. 228 69
7. 100
59
100 8 1 97 39 8
8. 69 100 1 12 2 99 1 42% 98 39% 3%
()
1. 100 12 765 54 100%
2. 5 1 4
() 1. DBPR104 99
7 30 11 23 FDA
60
2. DBPR108
3. 8 50 33 100 9
4. H5N1 1 1 100 6 99 8 2
61
5. B 100
6 17 100 7 22 B
6. /
7. AURORA Imaging Technology, Inc.
8.
62
()
1. 64 2005 14 10
2. (WHO) 100 5 16 6 (Mr. Burci) 4 Burci (take note of)
3. 100 10
63
4. APEC (HWG)(2011-2012)(Health Policy Dialogue) 100 3 9 9
5. APECRFID APEC 100 7 5 6 170 32 APEC 13
6. 100 9 24 25 2011 210
() 1.
64
3 100 12 19 9 13 (LNSP)
2. 100 7 449
3. 6000
4. (TaiwanIHA)(AMDA) 8 1 9 130
()
1.
65
2.
3. 100 23 146
4. 100 6 26 8 1 2
66
()100 51 1,443 66 582 4
1. (1)
(2) (3) (4) 2. (1)
(2)
67
(3) (4) (5)
1. APEC
2. 3. (1) (2) (3) (4)
1. (1) (2) (3) 2. (1)101
68
(2) 3. (1) 2
(2) 20 (3) (4)
1. 2. 55 64 3.
4. 5.
6. HPV
7.
1. 2. CDC 3.
69
4. Gastein European Health Forum 5.
11 45
70
96 98 100
1.
2.
3. 4.
2143 1500-1700
71
1.
2. 3. 4. 5.
1.
2.
72
IDS
3. (101-105 )
4.
1.
2. 101
1. 99 4 1
2.
73
1.
6 ()
2. 36
DRG
1. DRG
2.
74
100 1 26
30
1. 3
2.
3.
75
10-15 4.
1. 2. 3.
1. 71
2. 71
76
PCV 102-104 PCV
77
MIT
78
1.
2. 290
3.
4. 101 6
5. 100 101 102 101
79
102
101
80
81